Loading organizations...
Moonoa provides a digital program that integrates technology with cognitive behavioral therapy (CBT) to help individuals overcome various sleep disorders, including insomnia, narcolepsy, and parasomnia. The platform delivers a personalized program designed to improve sleep quality by addressing behavioral, psychological, and lifestyle factors. This approach focuses on comprehensive, non-pharmacological interventions to foster healthier sleep patterns.
The company was founded in 2021, with Pablo Szefner as its Co-Founder and CEO. Szefner brings prior entrepreneurial experience, having previously founded and led The Fab Shoes. The inception of Moonoa stemmed from the insight that a structured, evidence-based digital solution could make effective sleep therapy more accessible to a broader audience experiencing chronic sleep challenges.
Moonoa's product is utilized by individuals seeking to mitigate sleep disturbances and enhance their overall sleep health. The company's vision centers on empowering users to achieve sustainable improvements in their sleep and consequently their quality of life. It aims to offer a robust, personalized digital pathway for managing and resolving sleep issues long-term.
Moonoa has raised $2.0M across 1 funding round.
Moonoa has raised $2.0M in total across 1 funding round.
Moonoa has raised $2.0M in total across 1 funding round.
Moonoa's investors include 4Founders Capital, btov Partners, Invariantes Fund, Albert Armengol, Andreas Mihalovits, Eneko Knorr, Luis Martin Cabiedes, Albert Serrano Pons, Jose Marcilla, Marek Fodor, Mario Bruggemann, Cabiedes & Partners.
Moonoa is a Barcelona-based health tech company developing a digital therapeutics platform to combat sleep disorders like insomnia, narcolepsy, and parasomnia using cognitive behavioral therapy (CBT-i).[1][4] It serves individuals struggling with sleep issues by offering a personalized app with over 1,000 content pieces, monthly food supplements tailored to user profiles, and clinically validated programs that have shown 90% of patients reporting better sleep and over 80% reducing reliance on sleeping pills.[1][4] The company raised €1.54 million in a 2021 seed round led by Seedrocket 4founders, with participation from K Fund, Cabiedes, and notable angels, positioning it for growth in the booming digital health space amid rising insomnia post-Covid.[1]
Moonoa's solution is certified as a medical device by the Spanish Medicines Agency and the EU, emphasizing telemedicine's benefits like accessibility, cost reduction, and shorter wait times over traditional care.[1]
Founded in October 2020 by serial entrepreneurs Pablo Szefner (CEO), Caroline Jacquet, Fanny Dubrule, and David Rodriguez Ureña, Moonoa emerged as a direct response to the surge in insomnia exacerbated by Covid-19.[1] The team's entrepreneurial backgrounds drove the creation of a CBT-i-based platform, backed by over 100 clinical studies demonstrating strong efficacy.[1] Early traction included securing medical device certification and launching with app-based content and supplements, culminating in the €1.54 million seed raise in May 2021 to scale operations and reach more users.[1]
Moonoa rides the digital therapeutics wave, capitalizing on post-pandemic insomnia spikes and the shift to telemedicine for mental health.[1] Timing aligns with growing demand for non-pharmacological sleep solutions, as Covid accelerated sleep disorders while enabling app-based delivery that cuts costs and wait times.[1] Favorable market forces include EU regulatory support for medical devices and investor interest in health tech, as seen in its seed funding from prominent European VCs.[1] It influences the ecosystem by validating CBT-i scalability, potentially inspiring more startups in personalized wellness tech amid a global sleep crisis affecting productivity and mental health.
Moonoa is poised for expansion with its validated model, likely pursuing Series A funding to grow user base and internationalize beyond Europe, leveraging telemedicine trends.[1] Rising AI integration in health apps and sustained focus on mental wellness post-Covid will shape its path, with potential partnerships in wearables or pharma for broader adoption. Its influence could evolve from niche sleep aid to a leader in digital CBT, empowering millions to ditch pills for lasting habits—transforming how we tackle the modern insomnia epidemic that sparked its founding.[1][4]
Moonoa has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2021 | $2.0M Seed | 4Founders Capital | btov Partners, Invariantes Fund, Albert Armengol, Andreas Mihalovits, Eneko Knorr, Luis Martin Cabiedes, Albert Serrano Pons, Jose Marcilla, Marek Fodor, Mario Bruggemann, Cabiedes & Partners, K Fund |